STOCK TITAN

Avid Bioservices Set to Join S&P SmallCap 600

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

NEW YORK, Oct. 25, 2021 /PRNewswire/ -- Avid Bioservices Inc. (NASD: CDMO) will replace Cadence Bancorporation (NYSE: CADE) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, October 29. S&P MidCap 400 constituent BancorpSouth Bank (NYSE: BXS) is acquiring Cadence Bancorporation in a deal expected to close on or about that date pending final conditions.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date

Index Name      

Action

Company Name

Ticker

GICS Sector

October 29, 2021

S&P SmallCap 600

Addition

Avid Bioservices

CDMO

Health Care


S&P SmallCap 600

Deletion

Cadence Bancorporation

CADE

Financials

For more information about S&P Dow Jones Indices, please visit www.spdji.com

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

 

Cision View original content:https://www.prnewswire.com/news-releases/avid-bioservices-set-to-join-sp-smallcap-600-301408013.html

SOURCE S&P Dow Jones Indices

Avid Bioservices, Inc.

NASDAQ:CDMO

CDMO Rankings

CDMO Latest News

CDMO Stock Data

520.53M
58.33M
1.1%
91.92%
15.99%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
TUSTIN

About CDMO

avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.